| 3D printing of personalized thick and perfusable cardiac patches and hearts N Noor, A Shapira, R Edri, I Gal, L Wertheim, T Dvir Advanced science 6 (11), 1900344, 2019 | 956 | 2019 |
| 3D tissue and organ printing—hope and reality A Shapira, T Dvir Advanced Science 8 (10), 2003751, 2021 | 78 | 2021 |
| 693 A Novel Anti-CD24-Toxin Immunoconjugate for Targeted Therapy of Colorectal and Pancreatic Cancers S Shapira, S Kraus, D Kazanov, A Shapira, P Altevogt, I Benhar, N Arber Gastroenterology 5 (136), A-108-A-109, 2009 | | 2009 |
| 739 Successful Selective Eradication of Colorectal Cancer Cells by Adenovirus-Based Delivery of Toxins S Shapira, A Shapira, D Kazanov, I Naboichtchikov, S Kraus, N Arber Gastroenterology 148 (4), S-137-S-138, 2015 | | 2015 |
| 873 The “Trojan Horse” Strategy: Selective Eradication of Cancer Cells by Adenovirus-Based Delivery of Cytotoxic Agents: An Alternative Method for Targeting Pancreatic (PC) and … S Shapira, A Shapira, D Kazanov, S Kraus, M Oren, N Arber Gastroenterology 5 (146), S-152, 2014 | 1 | 2014 |
| A microfluidic chip containing multiple 3D nanofibrous scaffolds for culturing human pluripotent stem cells L Wertheim, A Shapira, RJ Amir, T Dvir Nanotechnology 29 (13), 13LT01, 2018 | 6 | 2018 |
| A stretchable and flexible cardiac tissue–electronics hybrid enabling multiple drug release, sensing, and stimulation R Feiner, L Wertheim, D Gazit, O Kalish, G Mishal, A Shapira, T Dvir Small 15 (14), 1805526, 2019 | 59 | 2019 |
| Activatable toxin complexes comprising a cleavable inhibitory peptide I Benhar, A Shapira, M Gal-Tanamy, D Greenfeld, L Nahary, R Zemel, ... US Patent 9,321,847, 2016 | 2 | 2016 |
| Advanced micro-and nanofabrication technologies for tissue engineering A Shapira, DH Kim, T Dvir Biofabrication 6 (2), 020301, 2014 | 35 | 2014 |
| Albumin fiber scaffolds for engineering functional cardiac tissues S Fleischer, A Shapira, O Regev, N Nseir, E Zussman, T Dvir Biotechnology and bioengineering 111 (6), 1246-1257, 2014 | 99 | 2014 |
| An immunoconjugate of anti-CD24 and Pseudomonas exotoxin selectively kills human colorectal tumors in mice S Shapira, A Shapira, A Starr, D Kazanov, S Kraus, I Benhar, N Arber Gastroenterology 140 (3), 935-946, 2011 | 59 | 2011 |
| Channeled ECM-based nanofibrous hydrogel for engineering vascularized cardiac tissues S Arvatz, L Wertheim, S Fleischer, A Shapira, T Dvir Nanomaterials 9 (5), 689, 2019 | 12 | 2019 |
| Chondroitin sulfate-AuNRs electroactive scaffolds for on-demand release of biofactors M Malki, A Shapira, T Dvir Journal of Nanobiotechnology 20 (1), 59, 2022 | 8 | 2022 |
| Composite biomaterial scaffolds for cardiac tissue engineering A Shapira, R Feiner, T Dvir International Materials Reviews 61 (1), 1-19, 2016 | 62 | 2016 |
| Effect of fiber diameter on the assembly of functional 3D cardiac patches S Fleischer, J Miller, H Hurowitz, A Shapira, T Dvir Nanotechnology 26 (29), 291002, 2015 | 55 | 2015 |
| Engineered hybrid cardiac patches with multifunctional electronics for online monitoring and regulation of tissue function R Feiner, L Engel, S Fleischer, M Malki, I Gal, A Shapira, ... Nature materials 15 (6), 679-685, 2016 | 415 | 2016 |
| Engineered toxins “zymoxins” are activated by the HCV NS3 protease by removal of an inhibitory protein domain A Shapira, M Gal-Tanamy, L Nahary, D Litvak-Greenfeld, R Zemel, ... PloS one 6 (1), e15916, 2011 | 11 | 2011 |
| Fabrication of omentum-based matrix for engineering vascularized cardiac tissues M Shevach, N Soffer-Tsur, S Fleischer, A Shapira, T Dvir Biofabrication 6 (2), 024101, 2014 | 46 | 2014 |
| Gold nanoparticle-decellularized matrix hybrids for cardiac tissue engineering M Shevach, S Fleischer, A Shapira, T Dvir Nano letters 14 (10), 5792-5796, 2014 | 274 | 2014 |
| Gold Nanoparticle-Decellularized Matrix Hybrids for Cardiac Tissue Engineering M Shevach, S Fleischer, A Shapira, T Dvir TISSUE ENGINEERING PART A 21, S210-S211, 2015 | | 2015 |
